Possible role of adenosine deaminase in vaso-occlusive diseases

Journal of Hypertension

Volumn 14, Issue 1, 1996, Pages 19-29

  Jackson, Edwin K ^a,b   Koehler, Maria ^a   Mi, Zaichuan ^a   Dubey, Raghvendra K ^a   Tofovic, Stevan P ^a   Carcillo, Joseph A ^a   Jones, Garth S ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Adenosine; Adenosine deaminase; Cyclic AMP; Erythrocyte; Sickle cell disease; Vaso occlusive diseases

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CYCLIC AMP; INOSINE; NITRIC OXIDE; RENIN;

BIOSYNTHESIS; BLOOD VESSEL OCCLUSION; CELL CULTURE; CELL GROWTH; ERYTHROCYTE; NONHUMAN; PRIORITY JOURNAL; RENIN RELEASE; REVIEW; SMOOTH MUSCLE FIBER; THROMBOCYTE AGGREGATION INHIBITION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0029926707     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199601000-00003     Document Type: Review

References (85)

1. Drury AN, Szent-Gyorgy A: The physiological activity of adenine compounds with special reference to their actions upon the mammalian heart. J Physiol 1929, 68:213-237.
2. Berne RM, Knabb RM, Ely SW, Rubio R: Adenosine in the local regulation of blood flow: a brief overview. Federation Proc 1983, 42:3136-3142.
3. Schrader J: Formation and metabolism of adenosine and adenine nucleotides in cardiac tissue. In Adenosine and Adenine Nucleotides as Regulators of Cellular Function. Edited by Phillis JW. Boca Raton, FL: CRC Press; 1991:55-69.
4. Hertz L: Nucleoside transport in cells: kinetics and inhibitor effects. In Adenosine and Adenine Nucleotides as Regulators of Cellular Function. Edited by Phillis JW. Boca Raton, FL: CRC Press; 1991:85-107.
5. Gordon JL: Extracellular ATP: effects, sources and fate. Biochem J 1986, 233:309-319.
6. Pearson JD, Gordon JL: Vascular endothelial and smooth muscle cells in culture selectively release adenine nucleotides. Nature 1979, 281:384-386.
7. LeRoy EC, Ager A, Gordon JL: Effects of neutrophil elastase and other proteases on porcine aortic endothelial prostaglandin 12 production, adenine nucleotide release, and responses to vasoactive agents. J Clin Invest 1984, 74:1003-1010.
8. Pearson JD, Carleton JS, Gordon JL: Metabolism of adenine nucleotides by ectoenzymes of vascular endothelial and smooth-muscle cells in culture. Biochem J 1980, 190:421-429.
9. Gordon EL, Pearson JD, Dickinson ES, Moreau D, Slakey LL: The hydrolysis of extracellular adenine nucleotides by arterial smooth muscle cells. Regulation of adenosine production at the cell surface. J Biol Chem 1989, 264:18986-18995.
10. Gordon EL, Pearson JD, Slakey LL: The hydrolysis of extracellular adenine nucleotides by cultured endothelial cells from pig aorta. Feed-forward inhibition of adenosine production at the cell surface. J Biol Chem 1986, 261:15496-15507.
11. Lloyd HG, Deussen A, Wuppermann H, Schrader J: The transmethylation pathway as a source for adenosine in the isolated guinea-pig heart. Biochem J 1988, 252:489-494.
12. Deussen A, Lloyd HG, Schrader J: Contribution of S-adenosylhomocysteine to cardiac adenosine formation. J Mol Cell Cardiol 1989, 21:773-782.
13. Kroll K, Decking UK, Dreikorn K, Schrader J: Rapid turnover of the AMP-adenosine metabolic cycle in the guinea pig heart. Circ Res 1993, 73:846-856.
14. Misumi Y, Ogata S, Hirose S, Ikehara Y: Primary structure of rat liver 5′-nucleotidase deduced from the cDNA. J Biol Chem 1990, 265:2178-2183.
15. Pearson JD, Gordon JL: Nucleotide metabolism by endothelium. Annu Rev Physiol 1985, 47:617-627.
16. Pearson JD, Coade SB, Cusack NJ: Characterization of ectonucleotidases on vascular smooth muscle cells. Biochem J 1985, 230:503-507.
17. Barber R, Butcher RW: The egress of cyclic AMP from metazoan cells. Adv Cyclic Nucleotide Res 1983, 15:119-138.
18. King CD, Mayer SE: Inhibition of egress of adenosine 3′,5′-monophosphate from pigeon erthrocytes. Mol Pharmacol 1974, 10:941-953.
19. Barber R, Butcher RW: The quantitative relationship between intracellular concentration and egress of cyclic AMP from cultured cells. Mol Pharmacol 1981, 19:38-43.
20. Mi Z, Jackson EK: Metabolism of exogenous cyclic AMP to adenosine in the rat kidney. J Pharmacol Exp Ther 1995, 273:728-733.
21. Beavo JA, Reifsnyder DH: Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends in Pharmacol Sci 1990, 11:150-155.
22. Zimmermann H: 5′-Nucleotidase: molecular structure and functional aspects. Biochem J 1992, 285:345-365.
23. Tofovic SP, Branch KR, Oliver RD, Magee WD, Jackson EK: Caffeine potentiates vasodilator-induced renin release. J Pharmacol Exp Ther 1991, 256:850-860.
24. Mi Z, Herzer WA, Zhang Y, Jackson EK: 3-Isobutyl-1-methylxanthine decreases renal cortical interstitial levels of adenosine and inosine. Lite Sci 1994, 54:PL277-PL282.
25. Dubey RK, Mi Z, Jackson EK: Vascular smooth muscle cells metabolize cyclic AMP to generate adenosine [abstract]. Hypertension 1995, 26:57.
26. Dalziel HH, Westfall DP: Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization. Pharmacol Rev 1994, 46:449-466.
27. Olah ME, Stiles GL: Adenosine receptor subtypes: characterization and therapeutic regulation. Annu Rev Pharmacol Toxicol 1995, 35:581-606.
28. Libert F, Schiffman SN, Lefort A, Parmentier M, Gerard C, Dumont JE, et al.: The orphan receptor cDNA RDC7 encodes an A1 adenosine receptor. EMBO J 1991, 10:1677-1682.
29. 1 adenosine receptor from rat brain. Mol Pharmacol 1991, 40:1-7.
30. Maenhaut C, Van Sande J, Libert F, Abramowicz M, Parmentier M, Vanderhaegen JJ, et al.: RDC8 codes for an adenosine A2 receptor with physiological constitutive activity. Biochem Biophys Res Commun 1990, 173:1169-1178.
31. 2 dopamine receptors in rat striatum. Mol Brain Res 1992, 14:186-195.
32. 2b-adenosine receptor. Mol Endocrinol 1992, 6:1598-1604.
33. 2b receptor from human brain. Biochem Biophys Res Commun 1992, 187:86-93.
34. 3 adenosine receptor. Proc Natl Acad Sci USA 1992, 89:7432-7436.
35. 3 adenosine receptor. Proc Natl Acad Sci USA 1993, 90:10365-10369.
36. 3 receptors mediate hypotension in the angiotensin II-supported circulation of the pithed rat. Br J Pharmacol 1993, 109:3-5.
37. 3 receptor-mediated hypotensive responses in the rat. Eur J Pharmacol 1994, 252:R5-R6.
38. 3 receptor-mediated hypotensive response in the rat. Eur J Pharmacol 1993, 250:185-188.
39. 3 receptor-mediated hypotension in the rat. Br J Pharmacol 1995, 115:945-952.
40. 2b receptors in the guinea pig aorta. Eur J Pharmacol 1992, 216:235-242.
41. 3H]adenosine binding in relation to adenylate cyclase activity. Naunyn Schmiedebergs Arch Pharmacol 1984, 325:226-233.
42. 3H]NECA binding sites by gel filtration. Naunyn Schmiedebergs Arch Pharmacol 1988, 337:64-68.
43. Cristalli G, Vittori S, Thompson RD, Padgett WL, Shi D, Daly JW, et al.: Inhibition of platelet aggregation by adenosine receptor agonists. Naunyn Schmiedebergs Arch Pharmacol 1994, 349:644-650.
44. Hedqvist P, Fredholm BB: Effects of adenosine on adrenergic neurotransmission; prejunctional inhibition and post-junctional enhancement. Naunyn Schmiedebergs Arch Pharmacol 1976, 293:217-223.
45. Enero MA, Saidman BQ: Possible feed-back inhibition of noradrenaline release by purine compounds. Naunyn-Schmiedeberg's Arch Pharmacol 1977, 297:39-46.
46. De Mey J, Burnstock G, Vanhoutte PM: Modulation of the evoked release of noradrenaline in canine saphenous vein via presynaptic receptors for adenosine but not ATP. Eur J Pharmacol 1979, 55:401-405.
47. Ekas RD Jr, Steenberg ML, Eikenburg DC, Lokhandwala MF: Presynaptic inhibition of sympathetic neurotransmission by adenosine in the rat kidney. Eur J Pharmacol 1981, 76:301-307.
48. Murray RD, Churchill PC: Effects of adenosine receptor agonists in the isolated, perfused rat kidney. Am J Physiol 1984, 247:H343-H348.
49. 2 adenosine receptor activation inhibits and stimulates renin secretion of rat renal cortical slices. J Pharmacol Exp Ther 1985, 232:589-594.
50. Murray RD, Churchill PC: Concentration dependency of the renal vascular and renin secretory responses to adenosine receptor agonists. J Pharmacol Exp Ther 1985, 232:189-193.
51. Churchill PC, Bidani A: Renal effects of selective adenosine receptor agonists in anesthetized rats. Am J Physiol 1987, 252:F299-F303.
52. Fredholm BB, Duner-Engstrom M, Fastbom J, Hu P-S, Van Der Ploeg I: Role of G proteins, cyclic AMP, and ion channels in the inhibition of transmitter release by adenosine. Ann N Y Acad Sci 1990, 604:276-288.
53. Jackson EK: Adenosine: a physiological brake on renin release. Annu Rev Pharmacol Toxicol 1991, 31:1-35.
54. Itoh H, Mukoyama M, Pratt R, Gibbons G, Dzau V: Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 1993, 91:2268-2274.
55. Daemen M, Lombardi D, Bosman F, Schwartz S. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 1991, 68:450-456.
56. Dubey RK, Jackson EK, Luscher TF: Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell: role of cyclic-nucleotides and angiotensin, receptors. J Clin Invest 1995, 96:141-149.
57. Scott-Burden T, Hahn A, Resink T, Buhler F: Modulation of extracellular matrix by angiotensin II: stimulated glycoconjugate synthesis and growth in vascular smooth muscle cells. J Cardiovasc Pharmacol 1990, 16:S36-S41.
58. Sung CP, Arleth AJ, Storer BL, Ohlstein EH: Angiotensin type 1 receptors mediate smooth muscle proliferation and endothelin biosynthesis in rat vascular smooth muscle. J Pharmacol Exp Ther 1994, 271:429-437.
59. Vaughan DE, Lazos SA, Tong K: Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. J Clin Invest 1995, 95:995-1001.
60. Feener EP, Northrup JM, Aiello LP, King GL: Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells. J Clin Invest 1995, 95:1353-1362.
61. Headrick JP, Berne RM: Endothelium-dependent and -independent relaxations to adenosine in guinea pig aorta. Am J Physiol 1990, 259:H62-H67.
62. Cronstein BN: Adenosine, an endogenous anti-inflammatory agent J Applied Physiol 1994, 76:5-13.
63. Yen MH, Wu CC, Chiou WF: Partially endothelium-dependent vasodilator effect of adenosine in rat aorta. Hypertension 1988, 11:514-518.
64. Vials A, Burnstock G: A2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: a role for nitric oxide. Br J Pharmacol 1993, 109:424-429.
65. Steinhorn RH, Morin FC 3rd, Van Wylen DG, Gugino SF, Giese EC, Russell JA:Endothelium- dependent relaxations to adenosine in juvenile rabbit pulmonary arteries and veins. Am J Physiol 1994, 266:H2001-H2006.
66. 2b receptor. Hypertension (in press).
67. Dubey RK, Gillespie D, Mi Z, Jackson EK: Smooth muscle cell-derived adenosine inhibits cell growth. Hypertension (in press).
68. 2 receptor agonist inhibits neointimal thickening after rat femoral artery endothelium injury. Eur J Pharmacol 1995, 281:205-207.
69. Cusack NJ, Hourani SMO: Adenosine, adenine nucleotides, and platelet function. In Adenosine and Adenine Nucleotides as Regulators of Cellular Function. Edited by Phillis, JW. Boca Raton, FL: CRC Press; 1991:121-131.
70. Anand-Srivastava MB, Franks DJ: Stimulation of adenylate cyclase by adenosine and other agonists in mesenteric artery smooth muscle cells in culture. Life Sci 1985, 37:857-867.
71. Silver PJ, Walus K, DiSalvo J: Adenosine-mediated relaxation and activation of cyclic AMP-dependent protein kinase in coronary arterial smooth muscle. J Pharmacol Exp Ther 1984, 228:342-347.
72. Sabouni MH, Cushing DJ, Makujina SR, Mustafa SJ: Inhibition of adenylate cyclase attenutates adenosine receptor-mediated relaxation in coronary artery. J Pharmacol Exp Ther 1991, 259:508-512.
73. Cushing DJ, Brown GL, Sabouni MH, Mustafa SJ: Adenosine receptor-mediated coronary artery relaxation and cyclic nucleotide production. Am J Physiol 1991, 261:H343-348.
74. Geiger JD, Padua RA, Nagy JI: Adenosine deaminase regulation of purine actions. In Adenosine and Adenine Nucleotides as Regulators of Cellular Function. Edited by Phillis JW. Boca Raton, FL: CRC Press; 1991:71-84.
75. Arch JR, Newsholme EA: Activities and some properties of adenylate cyclase and phosphodiesterase in muscle, liver and nervous tissues from vertebrates and invertebrates in relation to the control of the concentration of adenosine 3′:5′-cyclic monophosphate. Biochem J 1976, 158:603-622.
76. Willis EH, Carson DA, Shultz LD: Adenosine deaminase activity in recipients of bone marrow from immunodeficient mice homozygous for the wasted mutation. Biochem Biophys Res Comm 1987, 145:581-585.
77. Sharff AJ, Wilson DK, Chang Z, Quiocho FA: Refined 2.5 Å structure of murine adenosine deaminase at pH 6.0. J Mol Biol 1992, 226:917-921.
78. Daddona PE, Kelley WN: Human adenosine deaminase: purification and subunit structure. J Biol Chem 1977, 252:110-115.
79. Zhu Q, Matherne GP, Curnish RR, Tribble CG, Berne RM: Effect of adenosine deaminase on cardiac interstitial adenosine. Am J Physiol 1992, 263:H1322-H1326.
80. Andy RJ, Kornfeld R: The adenosine deaminase binding protein of human skin fibroblasts is located on the cell surface. J Biol Chem 1982, 257:7922-7925.
81. Meghji P, Middleton K, Hassall CJ, Phillips MI, Newby AC: Evidence for extracellular deamination of adenosine in the rat heart. Inter J Biochem 1988, 20:1335-1341.
82. Sen S, Hoffman GC, Stowe NT, Smeby RR, Bumpus FM: Erythrocytosis in spontaneously hypertensive rats. J Clin Invest 1972, 51:710-714.
83. Bruschi G, Minari M, Bruschi ME, Tacinelli L, Milani B, Cavatorta A, et al.: Similarities of essential and spontaneous hypertension. Volume and number of blood cells. Hypertension 1986, 8:983-989.
84. Pavlovic-Kentera V, Basara N, Jerkic M, Biljanovic-Paunovic L, Clemons GK, Milenkovic P, et al.: Erythrocytosis in spontaneously hypertensive rats. Exp Hematol 1988, 16:950-953.
85. Suno M, Shibota M, Nagaoka A: Effect of CV-2619 (idebenone) on the half-life and hemolysis of red blood cells in stroke-prone spontaneously hypertensive rats (SHRSP). Nippon Yakurigaku Zasshi 1984, 84:407-410.